ReviewFrontiers in oncology2024

Next generation selective estrogen receptor degraders in postmenopausal women with advanced-stage hormone receptors-positive, HER2-negative breast cancer.

Baha' Sharaf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.